← All trials
NCT06374459
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2024
- Primary completion
- Mar 31, 2032
- Completion date
- Mar 31, 2032
- First posted
- Apr 18, 2024
- Last posted
- Oct 22, 2024
- Enrollment
- 152
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Washington University in St. LouisLead sponsor
- Washington University in St. LouisOfficial
- Department of DefenseCollaborator
- Aclaris Therapeutics, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.